ACE/Angiotension receptors

Citations 531-540 of 995 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells

Karin Kohlstedt, Rudi Busse, and Ingrid Fleming
Hypertension 2005;45:126-132; published online before print as doi:10.1161/01.HYP.0000150159.48992.11 [Abstract] [Full text]  

Scientific Contributions
Angiotensin Subtype-2 Receptors Inhibit Renin Biosynthesis and Angiotensin II Formation

Helmy M. Siragy, Chun Xue, Peter Abadir, and Robert M. Carey
Hypertension 2005;45:133-137; published online before print as doi:10.1161/01.HYP.0000149105.75125.2a [Abstract] [Full text]  

Scientific Contributions
Angiotensin-(1–7) Attenuates Neointimal Formation After Stent Implantation in the Rat

Bas Langeveld, Wiek H. van Gilst, René A. Tio, Felix Zijlstra, and Anton J.M. Roks
Hypertension 2005;45:138-141; published online before print as doi:10.1161/01.HYP.0000149382.83973.c2 [Abstract] [Full text]  

Scientific Contributions
Renal Angiotensin II Type-2 Receptors Are Upregulated and Mediate the Candesartan-Induced Natriuresis/Diuresis in Obese Zucker Rats

Amer C. Hakam and Tahir Hussain
Hypertension published December 13, 2004, doi:10.1161/01.HYP.0000151622.47814.6f [Abstract]  

Scientific Contributions
Selective Angiotensin-Converting Enzyme C-Domain Inhibition Is Sufficient to Prevent Angiotensin I-Induced Vasoconstriction

Joep H.M. van Esch, Beril Tom, Vincent Dive, Wendy W. Batenburg, Dimitris Georgiadis, Athanasios Yiotakis, Jeanette M.G. van Gool, René J.A. de Bruijn, René de Vries, and A. H. Jan Danser
Hypertension published December 6, 2004, doi:10.1161/01.HYP.0000151323.93372.f5 [Abstract]  

Editorial Commentaries
Osteopontin: A Protective Mediator of Cardiac Fibrosis?

Kristof Graf and Philipp Stawowy
Hypertension 2004;44:809-810; published online before print as doi:10.1161/01.HYP.0000148459.25908.49 [Full text]  

Scientific Contributions
Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor

Matthew J. Huentelman, Jasenka Zubcevic, Jose A. Hernández Prada, Xiaodong Xiao, Dimiter S. Dimitrov, Mohan K. Raizada, and David A. Ostrov
Hypertension 2004;44:903-906; published online before print as doi:10.1161/01.HYP.0000146120.29648.36 [Abstract] [Full text]  

Scientific Contributions
Vascular Response to Angiotensin II Predicts Long-Term Prognosis in Patients Undergoing Coronary Artery Bypass Grafting

Pim van der Harst, Meint Volbeda, Adriaan A. Voors, Hendrik Buikema, Sven Wassmann, Michael Böhm, Georg Nickenig, and Wiek H. van Gilst
Hypertension 2004;44:930-934; published online before print as doi:10.1161/01.HYP.0000147823.50497.a9 [Abstract] [Full text]  

Scientific Contributions
Selective Silencing of Angiotensin Receptor Subtype 1a (AT_1aR) by RNA Interference

Jorge Vázquez, María F. Correa de Adjounian, Colin Sumners, Aaron González, Carlos Diez-Freire, and Mohan K. Raizada
Hypertension published November 29, 2004, doi:10.1161/01.HYP.0000150161.78556.c6 [Abstract]  

Scientific Contributions
Signaling via the Angiotensin-Converting Enzyme Enhances the Expression of Cyclooxygenase-2 in Endothelial Cells

Karin Kohlstedt, Rudi Busse, and Ingrid Fleming
Hypertension published November 29, 2004, doi:10.1161/01.HYP.0000150159.48992.11 [Abstract]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100